Prostatype Genomics enters into collaboration with Professor E. David Crawford, MD, University of California San Diego, in preparation for the commercial launch of Prostatype® in the United States
Prostatype Genomics announces that the company and Professor E. David Crawford, MD, an internationally recognized expert in prostate cancer, will be the first US urologist with access to the Prostatype® testing service for clinical use. Providing early access and partnering with Professor Crawford in preparation for release nationwide will help ensure that urologist’s expectations are met when launching this next generation of prognostic testing to benefit patients battling prostate cancer.Prostatype Genomics has recently communicated the fulfillment of several key regulatory milestones
